Villers-le-lac, France

Sovy Chao

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Janssen Sciences Ireland Unlimited Company. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Sovy Chao

Introduction

Sovy Chao is a notable inventor based in Villers-le-lac, France. He has made significant contributions to the field of antiviral research, particularly focusing on compounds that target respiratory syncytial virus (RSV). His work has implications for the development of effective treatments for viral infections.

Latest Patents

Sovy Chao holds a patent for "Heteroaromatic compounds having activity against RSV." This invention concerns compounds of formula (I) that exhibit antiviral activity, specifically inhibiting the replication of RSV. The patent also includes pharmaceutical compositions that incorporate these compounds for use in treating RSV infections.

Career Highlights

Chao is associated with Janssen Sciences Ireland Unlimited Company, where he applies his expertise in medicinal chemistry and virology. His work at this company has positioned him as a key player in the development of innovative antiviral therapies.

Collaborations

Sovy Chao has collaborated with several esteemed colleagues, including David Francis Alain Lançois and Jérome Émile Georges Guillemont. These collaborations have enhanced the research and development efforts in the field of antiviral compounds.

Conclusion

Sovy Chao's contributions to antiviral research, particularly through his patent on heteroaromatic compounds, highlight his role as an influential inventor in the pharmaceutical industry. His work continues to pave the way for advancements in the treatment of viral infections.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…